Updated Information Regarding Tirzepatide (Mounjaro) – for Obesity

NICE Update on Tirzepatide On December 23rd 2024, the National Institute for Health and Care Excellence (NICE) released an update regarding Tirzepatide, a new medication for managing obesity in addition to its use in diabetes. Delayed Availability Tirzepatide (Mounjaro) will start to become available in Newcastle soon. Specialist Access Initially, only patients in specialist weight…